Delivery Order SPE2DB22D2007-SPE2DB25FH6MB

Award Date 10/23/24
Potential Completion Date 11/14/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,418.06, is for the supply of PROMACTA 25 MG TABLET and has a performance period through March 17, 2025. The contract is a firm-fixed price delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply PROMACTA 12.5 mg tablets. The delivery order has a firm fixed price of $4,417.24 and a completion date of July 7, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides comprehensive pharmaceutical and medical supply support to military...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $13,251.75 firm-fixed-price delivery order is for the supply of PROMACTA 12.5 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 50 MG TABLET medical products. The firm fixed-price contract has a ceiling value of $8,026.53 and a period of performance through June 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of PROMACTA 75 MG TABLET UU 30S, a pharmaceutical product. The contract, valued at $10,852.00, has a firm fixed price pricing type and a completion date of September 18, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 50 MG TABLET UU 30S. The contract has a ceiling value of $8,026.53 and a period of performance through July 16, 2025. It is not set aside for any specific business size or type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PROMACTA 12.5 MG TABLET UU 30S, a specialty pharmaceutical product. The contract has a ceiling value of $15,996.72 and a period of performance through September 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,834.50 contract is for the supply of PROMACTA 12.5 MG TABLET, a prescription medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides comprehensive global pharmaceutical support to military healthcare programs. The...
This is a contract award to AmerisourceBergen Drug Corporation's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,242.58 firm-fixed price delivery order is for the supply of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order, valued at $7,242.58, is for the supply of PROMACTA 50 MG TABLET UU 30S, a prescription medication. This order is not set aside for any specific business type. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH6MB
    Delivery Order

This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,242.58 firm fixed-price contract is for the supply of PROMACTA 50 MG TABLET, with a period of performance through November 14, 2024.

The contract is part of a larger $999,999,999 IDC held by AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves as a primary vehicle for critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 1/22/25, 9:35 AM